Kura Oncology (KURA) Retained Earnings (2010 - 2026)

Kura Oncology (KURA) has 17 years of Retained Earnings data on file, last reported at -$1.2 billion in Q1 2026.

• On a quarterly basis, Retained Earnings fell 30.91% year-over-year to -$1.2 billion in Q1 2026; TTM through Mar 2026 was -$1.2 billion, a 30.91% decrease from a year earlier, with the FY2025 full-year figure at -$1.2 billion, down 153776.44% from the prior year.
• Retained Earnings for Q1 2026 stood at -$1.2 billion, down from -$1.2 billion in the prior quarter.
• Over the last five years, Retained Earnings for KURA reached as high as $1.1 million in Q3 2024 and fell as low as -$1.2 billion in Q1 2026.
• Historically, Retained Earnings has averaged -$475.9 million across 5 years, with a median of -$535.7 million in 2022.
• Across the five-year window, Retained Earnings sank 567486.59% in 2022 and soared 253.56% in 2025, its largest moves.
• Year by year, Retained Earnings stood at -$568.8 million in 2022, then decreased by 26.83% to -$721.4 million in 2023, then soared by 100.11% to $764000.0 in 2024, then plunged by 153776.44% to -$1.2 billion in 2025, then fell by 6.25% to -$1.2 billion in 2026.
• Per Business Quant data, the three most recent Retained Earnings figures were -$1.2 billion in Q1 2026, -$1.2 billion in Q4 2025, and -$1.1 billion in Q3 2025.